Author

Shugo Muratani

Boston Medical CenterORCID 0009-0008-4535-989XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Christopher M. HeaphyiD· 2 shared Carina ShiauiD· 1 shared Carlos F. Fernandez-del CastilloiD· 1 shared Cristina Rosa FerroneiD· 1 shared Genevieve Marie BolandiD· 1 shared Hannah I. HoffmaniD· 1 shared Ignaty LeshchineriD· 1 shared Jae Won ChoiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Christopher M. HeaphyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyClinical Cancer ResearchPeer-reviewedMar 18, 2026

Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumors

Jeanna M. Qiu, Jae Won Cho, Phuong Trang Nguyen…·William L. Hwang

This study identifies distinct malignant cell states and myeloid glutamate signaling in aggressive pancreatic neuroendocrine tumors, linking them to poor clinical outcomes and therapeutic vulnerabilities.

1 citation

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 2, 2026

Functional inactivation of the telomerase chaperone TCAB1 primes cells for the activation of ALT in osteosarcoma

Joshua Keegan, Sydney Sorbello, Joakin Mori…·Rachel Litman Flynn

The paper identifies structural variations in TP53 that inactivate TCAB1, a telomerase chaperone, and show these variations are prevalent in ALT-positive osteosarcoma tumors.

DOI 10.64898/2026.01.02.691864

humanwhole-genome sequencing

𝕏 PostBluesky